EBWM
TMO icon

Eagle Bluffs Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Eagle Bluffs Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17M Buy
4,416
+147
+3% +$79.8K 0.85% 31
2025
Q4 		$2.48M Buy
4,269
+137
+3% +$77.5K 1% 29
2025
Q3 		$2.01M Buy
4,132
+87
+2% +$40.5K 0.87% 31
2025
Q2 		$1.64M Buy
4,045
+48
+1% +$20.1K 0.78% 35
2025
Q1 		$1.99M Sell
3,997
-1
-0% -$542 1.05% 31
2024
Q4 		$2.08M Buy
3,998
+284
+8% +$156K 1.12% 28
2024
Q3 		$2.3M Buy
3,714
+23
+0.6% +$13.6K 1.24% 27
2024
Q2 		$2.04M Buy
3,691
+41
+1% +$23.5K 1.19% 26
2024
Q1 		$2.12M Buy
3,650
+38
+1% +$21.3K 1.32% 26
2023
Q4 		$1.92M Sell
3,612
-12
-0.3% -$5.81K 1.31% 25
2023
Q3 		$1.84M Sell
3,624
-354
-9% -$189K 1.41% 24
2023
Q2 		$2.08M Buy
3,978
+52
+1% +$28.1K 1.6% 21
2023
Q1 		$2.26M Buy
3,926
+497
+14% +$280K 1.86% 17
2022
Q4 		$1.89M Sell
3,429
-52
-1% -$27.6K 1.98% 16
2022
Q3 		$1.77M Sell
3,481
-1
-0% -$560 2.04% 13
2022
Q2 		$1.89M Buy
3,482
+227
+7% +$125K 2.04% 12
2022
Q1 		$1.92M Sell
3,255
-8
-0.2% -$4.6K 1.86% 13
2021
Q4 		$2.18M Buy
+3,263
New +$2.04M 2.27% 12

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eagle Bluffs Wealth Management's TMO Position: Q1 2026 in Review

Eagle Bluffs Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 3.4% in Q1 2026, buying an estimated $79.8K and bringing the position to 4,416 shares worth $2.17M. The position accounts for 0.85% of the portfolio, ranked #31.

Eagle Bluffs Wealth Management first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.48M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Eagle Bluffs Wealth Management held 4,416 shares of Thermo Fisher Scientific worth $2.17M as of Q1 2026.
  • Eagle Bluffs Wealth Management bought 147 Thermo Fisher Scientific shares in Q1 2026, an estimated $79.8K.
  • Thermo Fisher Scientific made up 0.85% of Eagle Bluffs Wealth Management's portfolio in Q1 2026, its #31 holding.
  • Eagle Bluffs Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
  • Eagle Bluffs Wealth Management's Thermo Fisher Scientific position peaked at $2.48M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Eagle Bluffs Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.